U.S. Markets open in 4 mins

Mirati Therapeutics (MRTX) Looks Good: Stock Gains 8.3%

Zacks Equity Research

Mirati Therapeutics, Inc. (MRTX) was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $21.58 to $27.84 over the past one month time frame.

The stock has witnessed four downward estimate revisions in the past 30 days. The Zacks Consensus Estimate has also moved down over same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher lasts.

Mirati Therapeutics carries a Zacks Rank #3 (Hold), while its Earnings ESP is negative.

A better-ranked stock in the med-biomed/gene industry is Gilead Sciences Inc. (GILD), sporting a Zacks Rank #1 (Strong Buy).

Is MRTX going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
MIRATI THERAPTC (MRTX): Free Stock Analysis Report
 
GILEAD SCIENCES (GILD): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research